Rafael Target of Unusually High Options Trading (NYSE:RFL)

Rafael Holdings, Inc. (NYSE:RFL) was the target of unusually large options trading activity on Tuesday. Stock traders acquired 2,906 call options on the stock. This represents an increase of 329% compared to the typical daily volume of 677 call options.

Institutional Investors Weigh In On Rafael

A number of institutional investors have recently bought and sold shares of RFL. Renaissance Technologies LLC grew its stake in Rafael by 59.1% during the first quarter. Renaissance Technologies LLC now owns 89,138 shares of the company’s stock valued at $111,000 after acquiring an additional 33,111 shares in the last quarter. Geode Capital Management LLC grew its stake in Rafael by 25.4% during the fourth quarter. Geode Capital Management LLC now owns 445,866 shares of the company’s stock valued at $526,000 after acquiring an additional 90,417 shares in the last quarter. Citadel Advisors LLC grew its stake in Rafael by 132.3% during the third quarter. Citadel Advisors LLC now owns 72,584 shares of the company’s stock valued at $99,000 after acquiring an additional 41,335 shares in the last quarter. Vanguard Group Inc. grew its stake in Rafael by 10.5% during the third quarter. Vanguard Group Inc. now owns 1,394,726 shares of the company’s stock valued at $1,897,000 after acquiring an additional 133,024 shares in the last quarter. Finally, Cable Car Capital LP purchased a new position in Rafael during the second quarter valued at $173,000. Hedge funds and other institutional investors own 11.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded shares of Rafael from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, May 28th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has a consensus rating of “Sell”.

Rafael Stock Performance

Shares of RFL stock opened at $1.92 on Wednesday. Rafael has a 52-week low of $1.12 and a 52-week high of $3.19. The firm has a market capitalization of $100.07 million, a PE ratio of -2.44 and a beta of 0.54. The stock has a fifty day simple moving average of $1.32 and a two-hundred day simple moving average of $1.29.

Rafael (NYSE:RFL) last issued its quarterly earnings results on Monday, March 16th. The company reported ($0.13) earnings per share (EPS) for the quarter. Rafael had a negative return on equity of 37.27% and a negative net margin of 2,846.60%.The business had revenue of $0.21 million during the quarter.

About Rafael

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia.